| Autor: |
Baker, Robert W., Bermanzdhn, Paul D., Wirshing, Donna Ames, Dhengappa, K. N. Roy |
| Zdroj: |
CNS Spectrums; March 1997, Vol. 2 Issue: 3 p26-36, 11p |
| Abstrakt: |
In the past decade, clozapine, risperidone, and olanzapine were marketed for the first time in the United States, and other new antipsychotic drugs are expected to follow soon. Also within the past decade, the efficacy of serotonin-reuptake inhibitors (SRIs) has been demonstrated in patients with obsessive-compulsive disorder (OCD) and the serotonin hypothesis of OCD has been articulated clearly. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
